Carbocaine W/ Neo-cobefrin

   
Google
 
Web NewDrugInformation.com

Carbocaine W/ Neo-cobefrin


Drug - Carbocaine W/ Neo-cobefrin
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Levonordefrin; Mepivacaine Hydrochloride
Multiple ingredients are in alphabetical order.

Strength - 0.05MG/ML;2%
The potency of the active ingredient(s), Levonordefrin; Mepivacaine Hydrochloride. May repeat for multiple part products.

Applicant - EASTMAN KODAK
The firm name holding legal responsibility for Carbocaine W/ Neo-cobefrin. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 012125
The FDA assigned number to Carbocaine W/ Neo-cobefrin. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Carbocaine W/ Neo-cobefrin. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AP
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Carbocaine W/ Neo-cobefrin was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Carbocaine W/ Neo-cobefrin. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Carbocaine W/ Neo-cobefrin is in. Format is RX, OTC, DISCN.

Applicant Full Name - Eastman Kodak Co
The full name of the firm holding legal responsibility for the new application of Carbocaine W/ Neo-cobefrin.

Carbocaine W/ Neo-cobefrin